Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -0.93% vs -4.70% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 90.09% vs -46.28% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 40.36% vs -39.18% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -17.92% vs -11.70% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Rohto Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -0.93% vs -4.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 19.91% vs 11.75% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 90.09% vs -46.28% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 42.06% vs -8.30% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 40.36% vs -39.18% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 13.26% vs 2.38% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -17.92% vs -11.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 386.15% vs 41.30% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






